FDA Issues Refusal to File Letter to Theratechnologies for sBLA Seeking Approval of Intramuscular Administration of Trogarzo

Trogarzo (ibalizumab-uiyk) is currently approved in combination with other antiretroviral therapy for heavily treatment-experienced adults with multidrug resistant HIV-1 infection who are failing their current antiretroviral regimen.

Source link
#FDA #Issues #Refusal #File #Letter #Theratechnologies #sBLA #Seeking #Approval #Intramuscular #Administration #Trogarzo